Chair
Members
Professor of Medicine; General Internal Medicine and Geriatrics
Infection Prevention and Control Advisor and Referent
Clinical Professor and Senior Investigator
Water, Hygiene and Sanitation Technical Advisor
IFRC lead for public health in emergencies
Professor of Medicine, Yong Loo Lin School of Medicine, NUS, Group Chief of Medicine, National University Health System (NUHS)
Professor of Medicine at the University of Toronto and Chief of the trauma-critical care program at Sunnybrook Health Sciences Centre. Director for the Dalla Lana School of Public Health’s Institute
Infection Prevention and Control Nurse
AUB GRADE Coordinator and Clinical Epidemiology Unit Coordinator
The Alliance for International Medical Action (ALIMA) President and Medical Advisor
Professor in Civil and Environmental Engineering
PhD candidate; global health researcher and consultant with a specialty in primary and secondary impacts of epidemics (particularly Ebola and Covid-19).
Retired Professor of IPC and Chair Education Committee ICAN
Public Health Specialist
Survivor, Patient and health worker representative
Epidemiologist in the International Infection Control Program within the Division of Healthcare Quality Promotion, U.S Centers for Disease Control and Prevention
Disclaimer:
In order to enhance its management of conflicts of interest as well as strengthen public trust and transparency in connection with WHO meetings and activities involving the provision of technical/normative advice, the names and brief biographies of individuals (“Published Information”) being considered for participation in a WHO-convened Guideline Development Group are disclosed for public notice and comment. Comments may be sent to WHE_IPC_1@who.int.
The Published Information is provided by the experts themselves and is the sole responsibility of the individuals concerned. WHO is not responsible for the accuracy, veracity and completeness of the Published Information provided. Furthermore, in no event will WHO be responsible or liable for damages in relation to the use of, and reliance upon, the Published Information.
The comments received by WHO through the public notice and comment process are treated confidentially and their receipt will be acknowledged through a generic email notification to the sender. Comments brought to the attention of WHO through this process are an integral component of WHO’s conflict of interest assessment process and are carefully reviewed. WHO reserves the right to discuss information received through this process with the relevant expert and disclose to this expert the name and affiliation of the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management action in accordance with its policies.
Guideline Development Groups provide technical and/or normative advice and recommendations to WHO. Participation in a Guideline Development Group convened by WHO does not necessarily mean that the views expressed by the expert concerned are shared by WHO and/or represent the decisions or stated policy of WHO.
The list of participating experts, a summary of relevant interests disclosed by such experts, and any appropriate mitigation measures taken by WHO relating to the management of conflicts of interests, will be reported publicly in accordance with WHO policies.